CN104610229B - Synthesis method of ATP competitive small-molecule AKT inhibitor A443654 - Google Patents

Synthesis method of ATP competitive small-molecule AKT inhibitor A443654 Download PDF

Info

Publication number
CN104610229B
CN104610229B CN201510030110.7A CN201510030110A CN104610229B CN 104610229 B CN104610229 B CN 104610229B CN 201510030110 A CN201510030110 A CN 201510030110A CN 104610229 B CN104610229 B CN 104610229B
Authority
CN
China
Prior art keywords
compound
reaction
feed ratio
molar feed
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510030110.7A
Other languages
Chinese (zh)
Other versions
CN104610229A (en
Inventor
郑保富
高强
李硕梁
杨成武
周益南
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Hao Yuan pharmaceutical Limited by Share Ltd
Original Assignee
SHANGHAI HAOYUAN CHEMICAL TECHNOLOGY Co Ltd
SHANGHAI HAOYUAN CHEMEXPRESS BIO-PHARMACEUTICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI HAOYUAN CHEMICAL TECHNOLOGY Co Ltd, SHANGHAI HAOYUAN CHEMEXPRESS BIO-PHARMACEUTICAL TECHNOLOGY Co Ltd filed Critical SHANGHAI HAOYUAN CHEMICAL TECHNOLOGY Co Ltd
Priority to CN201510030110.7A priority Critical patent/CN104610229B/en
Publication of CN104610229A publication Critical patent/CN104610229A/en
Application granted granted Critical
Publication of CN104610229B publication Critical patent/CN104610229B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention discloses a synthesis method of an ATP competitive small-molecule AKT inhibitor A443654. According to the method, a compound 1 is used as a starting raw material, and the compound 6 (A-443654) is obtained through amino group protection, Suzuki reaction and protecting group removal. Usage of poisonous reagent hexamethylditin is avoided, the method is high in safety, environment-friendly, high in reaction yield and suitable for industrial large-scale production, the reaction time is shortened, and the process cost is reduced. The flow chart of the synthesis method is shown in the specification.

Description

A kind of be atp competitiveness small molecule akt inhibitor a443654 synthetic method
Technical field:
The present invention relates to a kind of preparation method of compound, particularly a kind of atp competitiveness small molecule akt inhibitor The synthetic method of a443654.
Background technology:
Pi3k/akt/mtor signal path is intracellular important signal transduction pathway, the impact metabolism of cell, increment, Transcription, survival and the aspect such as Angiogenesiss, have close relationship with the occurrence and development of various tumours, and also with glycosuria Disease, disease of cardiovascular system are relevant.Akt is also called protein kinase b (protein kinase b, pkb), be a kind of serine/ Serineprotein kinase.Pi3k/akt signal transduction is in the state of activation in the normal tissue, and when this path excessive activation, P-akt over-expresses, then may be by lowering the modes such as tumor suppressor protein p53, stimulating protein synthesis, inhibited apoptosis Lead to the unlimited increment of tumour cell.Therefore suppress the activation of this path, the programmed cell death of cancer cell can be promoted, be conducive to tumour Treatment.Various small molecule akt inhibitor are reported the clinical research entering oncotherapy, such as breast cancer, prostatitis successively at present Gland cancer, myelogenous leukemia, lymphocytic leukemia, myeloma etc..
A443654 is the representative of atp competitiveness small molecule akt inhibitor, will be used for the treatment of multiple solid tumors.Its chemistry Entitled (s) -1- (1h- indol-3-yl) -3- (5- (3- methyl isophthalic acid h- indazole -5- base) pyridin-3-yl epoxide) propyl- 2- amine, English Entitled (s) -1- (1h-indol-3-yl) -3- [5- (3-methyl-1h-indazol-5-yl) pyridin-3-yloxy] Propan-2-amine, its structural formula is as shown in Equation 6:
According to patent us20030199511 and document bioorganic&medicinal chemistry 2006,14, 6832 6846 reports, disclose a kind of preparation method of a-443654, flow chart as shown in Figure 1.
The method, with compound 4 as initiation material, obtains compound 6 through 3 step reactions, total recovery is 13%.This synthesizes road The shortcoming of line is to have used highly toxic hexa methyl ditin reagent, and the preparation reaction time length of tin reagent intermediate 5a, receipts Rate is low.Whole piece route economy is low, total recovery is low, process costs are high, environment is unfriendly, be unfavorable for that industrialization is amplified.
In view of there is reactions steps complexity, technology high cost, overall yield in the synthetic method having prepared this compound 6 Low shortcoming it is therefore desirable to develop a kind of more economical, efficiently, environmental protection, easy variation route, be beneficial to industrialized production.
Content of the invention
The invention discloses a kind of synthetic method of atp competitiveness small molecule akt inhibitor a443654, the method is to change Compound 1 is initiation material, obtains compound 6 (a-443654) and (sees below through amido protecting, suzuki reaction, protection group removing Figure).This method avoid the use of poisonous reagent hexa methyl ditin, security is good, environmentally friendly, and when shortening reaction Between, reaction yield is high, reduce process costs, be suitable for industrialization large-scale production.
With reference to specific embodiment, the present invention is expanded on further.It should be understood that these embodiments are merely to illustrate the present invention Rather than restriction the scope of the present invention.The experimental technique of unreceipted actual conditions in the following example, generally according to conventional strip Part is carried out.
In embodiment, raw material used or reagent are in addition to special instruction, all commercially available.
Room temperature described in embodiment refers both to 20~35 DEG C.Unless otherwise indicated, described reagent is not purified directly makes With.All solvents are purchased from commercialization supplier, such as aldrich (aldrich), and not treated can use.Reaction Analyzed by tlc and/or analyzed by lc-ms, judge the termination reacted by the consumption of parent material.The thin layer of analysis Chromatography (tlc) is the glass plate (emd chemical company (emd chemicals)) in pre-coated silica gel 60f2540.25 millimeter plate On carry out, with the iodine developing on uv light (254nm) and/or silica gel, and/or with tlc product dyed thereby such as alcohol phosphomolybdic acid, hydration indenes Triketone solution, liquor potassic permanganate or ceric sulfate solution heat together.
1h-nmr spectrum is on ten thousand Ruian-Mo Qiuli-vx400 (varian mercury-vx400) instrument, in 400mhz behaviour Make lower record.
Used in the present invention, abbreviation has this area conventional sense, such as: dcm represents dichloromethane, and dmso represents diformazan Base sulfoxide.
The preparation method of the present invention can be represented with the flow process shown in accompanying drawing 2.
More specifically, the preparation method of the present invention comprises following process:
1) compound 1 in the basic conditions, is reacted with conventional amido protecting agent, prepared compound 2.
Wherein r defines with accompanying drawing 2.
Described alkali can be sodium carbonate, potassium carbonate, cesium carbonate, sodium acid carbonate, saleratus, NaOH, potassium hydroxide, Lithium hydroxide, the inorganic base such as barium hydroxide, or the organic base such as pyridine, triethylamine, diisopropyl ethyl amine, or p-methyl benzenesulfonic acid pyrrole Pyridine, wherein it is preferred that triethylamine.The molar feed ratio of described alkali and compound 1 is 0.05~15:1, preferably 0.05~ 5:1.
Amido protecting agent can be di-tert-butyl dicarbonate (boc2O), benzyl chloroformate (cbzcl), chloro-carbonic acid -9- fluorenes Base methyl esters (fmoc-cl), allyl chlorocarbonate (alloc-cl), dihydro pyranyl (dhp), n- [2- (trimethyl silicon substrate) ethoxy Carbonyloxy group] succinimide (teoc succinimide) etc., wherein it is preferred that di-tert-butyl dicarbonate or benzyl chloroformate or Dihydro pyranyl (dhp).The molar feed ratio of described amido protecting agent and compound 1 is 1~10:1, preferably 1~3:1.
Reaction temperature is room temperature to solvent reflux temperature, preferably reflux temperature.
The solvent being suitable for above-mentioned reaction is acetonitrile, dichloromethane, ethanol, methyl alcohol, oxolane, dmf, dioxane, second Acetoacetic ester, toluene, any combination of chloroform etc. or above-mentioned solvent.A kind of preferred solvent is chloroform.
2) in the basic conditions, palladium reagent catalysis is lower and connection boric acid pinacol ester occurs suzuki coupling reaction for compound 2, Prepared compound 3.
Wherein r defines with accompanying drawing 2.
Described alkali can be sodium carbonate, potassium carbonate, cesium carbonate, sodium acid carbonate, saleratus, NaOH, potassium hydroxide, Lithium hydroxide, potassium tert-butoxide, sodium tert-butoxide, the inorganic base such as potassium acetate, or pyridine, triethylamine, diisopropyl ethyl amine etc. are organic Alkali, wherein it is preferred that potassium acetate, and described alkali is 1~10:1, preferably 1~3:1 with the molar feed ratio of compound 2.
Described palladium reagent can be pd (dppf) cl2, pd2(dba)3, pd (pph3)4, pd (oh)2, pd (oac)2, wherein excellent Choosing is pd (dppf) cl2.Described palladium reagent is 0.01~0.5:1 with the molar feed ratio of compound 2, preferably 0.05~ 0.3:1.
Reaction temperature is room temperature to solvent reflux temperature, preferably reflux temperature.
The solvent being suitable for above-mentioned reaction is dmso, acetonitrile, dichloromethane, ethanol, methyl alcohol, oxolane, dmf, dioxy six Ring, ethyl acetate, any combination of toluene etc. or above-mentioned solvent.A kind of preferred solvent is dmso.
The molar feed ratio of connection boric acid pinacol ester and compound 2 is 1~10:1, excellent for electing 1~1.5:1 as.
Reaction time detecting that reaction completes, usually 1~48 hour, preferably 12~16 hours.
3) compound 4 and compound 3, under conditions of alkali, carries out suzuki coupling reaction, preparedization under palladium reagent catalysis Compound 5.
Wherein r defines with accompanying drawing 2.
Described alkali can be sodium carbonate, potassium carbonate, cesium carbonate, sodium acid carbonate, saleratus, NaOH, potassium hydroxide, Lithium hydroxide, potassium tert-butoxide, sodium tert-butoxide, the inorganic base such as potassium acetate, or pyridine, triethylamine, diisopropyl ethyl amine etc. are organic Alkali, wherein it is preferred that sodium carbonate, and described alkali is 1~10:1, preferably 1~4:1 with the molar feed ratio of compound 4.
Described palladium reagent can be pd (dppf) cl2, pd2(dba)3, pd (pph3)4, pd (oh)2, pd (oac)2, wherein excellent Choosing is pd (dppf) cl2.Described palladium reagent is 0.01~0.5:1 with the molar feed ratio of compound 2, preferably 0.03~ 0.3:1.
Reaction temperature is room temperature to solvent reflux temperature, preferably reflux temperature.
The solvent being suitable for above-mentioned reaction is dmso, acetonitrile, dichloromethane, ethanol, methyl alcohol, oxolane, dmf, dioxy six Ring, ethyl acetate, toluene, any combination of water etc. or above-mentioned solvent.A kind of preferred solvent is the mixing of dioxane and water Thing.
The volume ratio of dioxane and water is 10~1:1, excellent for electing 3~1:1 as.
Compound 3 is 1~10:1 with the molar feed ratio of compound 4, excellent for electing 1~1.2:1 as.
Reaction time detecting that reaction completes, usually 1~48 hour, preferably 12~16 hours.
4) compound 5 sloughs amino protecting group, prepared compound 6, and the described method of Deprotection and condition can be this The conventional method of the such reaction in field and condition.
The advantage of the inventive method essentially consists in:
1) avoid the use of high toxicity hexa methyl ditin reagent, and use eco-friendly borane reagent instead.
2) preparation of contrast existing report method key tin reagent intermediate, the preparation of borane reagent intermediate in the method Reaction time greatly shortens, and yield increases substantially.
3) committed step suzuki coupling reaction, easy and simple to handle, yield is up to 73%, and whole piece synthetic route gross production rate is 63%.
This method is a brand-new synthetic route capable of being industrialized.Meanwhile, this route has to developing new inhibitor Methodology meaning well.
Brief description
Fig. 1 is the flow chart of a-443654 synthetic method disclosed in patent us20030199511;
Fig. 2 is the flow chart of akt inhibitor a443654 synthetic method of the present invention, wherein: r be THP trtrahydropyranyl (thp) or Person's tertbutyloxycarbonyl (boc) or benzyloxycarbonyl group (cbz), fluorenylmethyloxycarbonyl (fmoc) or allyloxycarbonyl (alloc) or Trimethylsilyl ethoxycarbonyl (teoc).
Specific embodiments
With reference to specific embodiment, the present invention is expanded on further.It should be understood that these embodiments are merely to illustrate the present invention Rather than restriction the scope of the present invention.The experimental technique of unreceipted actual conditions in the following example, generally according to conventional strip Part is carried out.
Embodiment 1: the preparation of compound 2
Addition compound 1 (50g, 237mmol, 1eq) in 500ml there-necked flask, 3,4- dihydropyran (60g, 713mmol, 3eq), p-methyl benzenesulfonic acid pyridine (3g, 11.8mmol, 0.05eq), chloroform (250ml, 5v), it is heated to back flow reaction 3 hours, Tlc detection raw material reaction is complete.Reaction system is down to room temperature, adds saturated sodium bicarbonate aqueous solution (500ml), stirs 5 minutes, Standing, separates organic phase, aqueous phase chloroform (200ml) extracts 1 time again, merges organic phase, with saturated aqueous common salt (500ml) and water (500ml) respectively wash once, anhydrous sodium sulfate drying, be concentrated to give black liquor (70g, y=100%).
1h nmr(cdcl3,500mhz):δppm 7.72(s,1h),7.53(s,1h),7.29(s,1h),5.62(m, 1h),4.10(m,1h),3.73(m,1h),2.63(s,3h),2.19(m,1h),2.09(m,1h),1.65(m,4h);esi/ms: M/z=295 (m+h)+.
Embodiment 2: the preparation of compound 3
In the there-necked flask of 1l, addition compound 2 (50g, 168.8mmol, 1eq), connection boric acid pinacol ester (45g, 177.3mmol, 1.05eq), potassium acetate (50g, 506.5mmol, 3eq) and dmso (500ml), stir under nitrogen protection 15min, adds pd (dppf) cl2(6.9g, 8.44mmol, 0.05eq), nitrogen displacement, it is heated to 70 DEG C, reaction overnight.lcms Monitoring raw material reaction is complete, is down to room temperature, adds water (500ml), ethyl acetate (500ml), silica gel (50g), mistake after stirring 5 minutes Filter.Separate organic phase, aqueous phase ethyl acetate (500ml) extracts 1 time again.Merge organic phase, washed once with saturated common salt, no Aqueous sodium persulfate is dried, and is concentrated to give black liquor 57.1g, y=100%).Without purifying, it is directly used in the next step.
1h nmr(cdcl3,500mhz):δppm 8.32(s,1h),8.13(s,1h),7.62(s,1h),5.80(m, 1h),4.13(m,1h),3.83(m,1h),2.65(s,3h),2.23(m,1h),2.12(m,1h),1.75(m,4h),1.25(s, 12h);Esi/ms:m/z=343 (m+h)+.
Embodiment 3: the preparation of compound 5
In 3l there-necked flask, add compound 4 (150g, 336mmol, 1eq), compound 3 (138g, 403.3mmol, 1.2eq), sodium carbonate (142.5g, 1344.3mmol, 4eq), dioxane (900ml, 6v), water (600ml, 4v), nitrogen is protected Lower addition pd (dppf) cl2(8.2g, 10.1mmol, 0.03eq), nitrogen displacement, then heat to 75 degree of reaction overnight.lcms Monitoring raw material reaction is complete.Add water (1.5l), ethyl acetate (1.5l), silica gel (150g), stir 10min, filter, filtrate is divided Go out organic layer, aqueous phase is extracted 1 time with ethyl acetate (1.5l), merge organic phase, organic phase saturated aqueous common salt (1.5l) washes 1 Secondary, anhydrous sodium sulfate drying, it is concentrated to give dark oil produce product (143.2g, y=73%).
1h nmr(cd3od,500mhz):δppm 8.45(s,1h),8.25(brs,1h),7.98(s,1h),7.61(m, 4h),7.37(s,1h),7.16(s,1h),7.10(m,1h),7.00(m,1h),5.80(s,1h),4.18(m,1h),4.03(m, 1h),3.65(m,2h),3.56(m,1h),3.10(m,1h),3.00(m,1h),2.62(s,3h),2.17-1.92(m,2h), 1.55-1.65(m,4h),1.38(s,9h);Esi/ms:m/z=583 (m+h)+.
Embodiment 4: the preparation of compound 6
By compound 5 (104g, 178.9mmol), methyl alcohol (620ml, 6v) is added in 1l there-necked flask, and temperature control is less than 25 DEG C Dropping 4m hcl/ ethyl acetate (130ml) solution, reaction overnight, tlc monitoring raw material reaction completely, concentrates, and oil pump draws dry 104g crude product, adds water (900ml), ethyl acetate (1350ml), stirs to system clarification, standing, separates organic layer, aqueous phase is used Ethyl acetate (500ml) extracts 1 time again, merges organic phase, adds water (180ml), concentrates most of ethyl acetate, to starting Have solid separate out, ice bath cool down, stirring and crystallizing 30min, filter, filter cake dry after white solid (57.9g, yield 86%, pure Degree 98.3%).
1h nmr(cd3od,500mhz):δppm 8.45(s,1h),8.25(brs,1h),7.98(s,1h),7.61(m, 4h),7.37(s,1h),7.16(s,1h),7.10(m,1h),7.00(m,1h),4.18(m,1h),4.03(m,1h),3.56(m, 1h),3.10(m,1h),3.00(m,1h),2.62(s,3h);Esi/ms:m/z=398 (m+h)+.
Embodiment 5: the preparation of compound 7
Addition compound 1 (50g, 237mmol, 1eq) in 500ml there-necked flask, triethylamine (72g, 713mmol, 3eq), two Dimethyl dicarbonate butyl ester (51.7g, 237mmol, 1.0eq), dichloromethane (250ml, 5v), mixture reacts 3 hours at room temperature, Tlc detection raw material reaction is complete.Add water (500ml) toward reaction system, stir 5 minutes, standing, separate organic phase, aqueous phase is used Dichloromethane (200ml) extracts 1 time again, merges organic phase, is respectively washed once with saturated aqueous common salt (500ml) and water (500ml), no Aqueous sodium persulfate is dried, and is concentrated to give black liquor (73g, y=100%).
1h nmr(cdcl3,500mhz):δppm 8.21(s,1h),8.02(s,1h),7.51(s,1h),2.06(s, 3h),1.38(s,9h);Esi/ms:m/z=311 (m+h)+.
Embodiment 6: the preparation of compound 8
In the there-necked flask of 1l, addition compound 7 (52g, 168.8mmol, 1eq), connection boric acid pinacol ester (42.9g, 168.8mmol, 1eq), sodium acid carbonate (14.2g, 168.8mmol, 1eq) and dmso (500ml), stir under nitrogen protection After 15min, add pd (dppf) cl2(1.38g, 1.7mmol, 0.01eq), is heated to after nitrogen displacement flowing back, reacts 1 hour. Lcms monitoring raw material reaction is complete, is down to room temperature, adds water (500ml), ethyl acetate (500ml), silica gel (50g), stirs 5 minutes After filter.Separate organic phase, aqueous phase ethyl acetate (500ml) extracts 1 time again.Merge organic phase, wash one with saturated common salt Secondary, anhydrous sodium sulfate drying, it is concentrated to give black liquor 60.3g, y=100%).Without purifying, it is directly used in the next step.
1h nmr(cdcl3,500mhz):δppm 8.32(s,1h),8.13(s,1h),7.62(s,1h),2.06(s, 3h),1.38(s,9h),1.25(s,12h);Esi/ms:m/z=359 (m+h)+.
Embodiment 7: the preparation of compound 9
In 3l there-necked flask, add compound 4 (150g, 336mmol, 1eq), compound 8 (120g, 336mmol, 1eq), carbon Sour sodium (35.6g, 336mmol, 1eq), dioxane (1500ml, 10v), water (150ml, 1v), nitrogen protection is lower to add pd (dppf)cl2(2.5g, 3.36mmol, 0.01eq), nitrogen displacement, it is warming up to backflow, reacts 1 hour, lcms monitoring raw material is anti- Should be completely.Add water (1.5l), ethyl acetate (1.5l), silica gel (150g), stir 10min, filter, filtrate separates organic layer, Aqueous phase is extracted 1 time with ethyl acetate (1.5l), merges organic phase, and organic phase saturated aqueous common salt (1.5l) washes 1 time, anhydrous slufuric acid Sodium is dried, and is concentrated to give dark oil produce product (122.4g, y=61%).
1h nmr(cd3od,500mhz):δppm 9.0(s,1h),8.38(s,1h),8.25(brs,1h),8.07(m, 2h),7.60-7.63(m,3h),7.32(m,1h),7.18(s,1h),7.11(m,2h),4.48(s,1h),3.81(s,1h), 3.56(m,1h),2.81(m,1h),2.56(m,1h),2.06(s,3h),1.38(s,18h);Esi/ms:m/z=598 (m+h) +.
Embodiment 8: the preparation of compound 6
By compound 9 (122.4g, 204.7mmol), methyl alcohol (750ml, 6v) is added in 1l there-necked flask, and temperature control is less than 25 The solution of dropping 4m hcl/ ethyl acetate (150ml) at DEG C, ambient temperature overnight is reacted, and tlc monitoring raw material reaction completely, concentrates, oil Pump draws dry compound 6 crude product, recrystallizes to obtain white solid (66.7g, yield 82%, purity 98.1%).
1h nmr(cd3od,500mhz):δppm 8.45(s,1h),8.25(brs,1h),7.98(s,1h),7.61(m, 4h),7.37(s,1h),7.16(s,1h),7.10(m,1h),7.00(m,1h),4.18(m,1h),4.03(m,1h),3.56(m, 1h),3.10(m,1h),3.00(m,1h),2.62(s,3h);Esi/ms:m/z=398 (m+h)+.
Embodiment 9: the preparation of compound 10
Compound 1 (50g, 238mmol, 1eq), triethylamine (360g, 3.57mol, 15eq), chloromethane is added in 1l there-necked flask Acid benzyl ester (406g, 2380mmol, 10eq), oxolane (250ml, 5v), slow temperature rising reflux, reacts 3 hours, tlc detects Raw material reaction is complete.Add the aqueous solution (500ml), the ethyl acetate (300ml) of potassium carbonate toward reaction system, stir 5 minutes, quiet Put, separate organic phase, aqueous phase ethyl acetate (200ml) extracts 1 time again, merge organic phase, with saturated aqueous common salt (500ml) and Water (500ml) is respectively washed once, anhydrous sodium sulfate drying, is concentrated to give black liquor (82g, y=100%).
1h nmr(cdcl3,500mhz):δppm 8.21(s,1h),8.02(s,1h),7.51-7.38(m,6h),5.18 (s,2h),2.08(s,3h)ppm;Esi/ms:m/z=345 (m+h)+.
Embodiment 10: the preparation of compound 11
In the there-necked flask of 3l, addition compound 10 (82g, 238mmol, 1eq), connection boric acid pinacol ester (604g, 2380mmol, 10eq), sodium carbonate (252g, 2380mmol, 10eq) and thf (800ml), stir 15min under nitrogen protection Afterwards, add pd (dppf) cl2(87g, 119mmol, 0.5eq), room temperature reaction 48 hours after nitrogen displacement.Lcms monitoring raw material is anti- Should be complete, it is down to room temperature, adds water (500ml), ethyl acetate (500ml), silica gel (80g), stirring was filtered after 5 minutes.Separate Machine phase, aqueous phase ethyl acetate (500ml) extracts 1 time again.Merge organic phase, washed once with saturated common salt, anhydrous sodium sulfate It is dried, be concentrated to give black liquor 93g, y=100%.Without purifying, it is directly used in the next step.
1h nmr(cdcl3,500mhz):δppm 8.32(s,1h),8.13(s,1h),7.62(s,1h),7.47-7.38 (m,5h),5.18(s,2h),2.06(s,3h),1.25(s,12h)ppm;Esi/ms:m/z=392 (m+h)+.
Embodiment 11: the preparation of compound 12
Toward in 250ml there-necked flask, add compound 4 (10.5g, 23.7mmol, 1eq), compound 11 (93g, 237mmol, 10eq), sodium carbonate (25.1g, 237mmol, 10eq), dioxane (50ml, 5v), water (50ml, 5v), nitrogen protection is lower to be added pd(dppf)cl2(8.7g, 11.85mmol, 0.5eq), nitrogen displacement, room temperature reaction 48 hours, lcms monitoring raw material reaction is complete Entirely.Add water (500ml), ethyl acetate (250ml), silica gel (10g), stir 10min, filter, filtrate separates organic layer, aqueous phase Extracted 1 time with ethyl acetate (250ml), merge organic phase, organic phase saturated aqueous common salt (300ml) washes 1 time, anhydrous sodium sulfate It is dried, be concentrated to give dark oil produce product (9.4g, y=63%).
1h nmr(cd3od,500mhz):δppm 9.08(s,1h),8.41(s,1h),8.29(brs,1h),8.10(m, 2h), 7.67-7.61 (m, 3h), 7.47-7.32 (m, 6h), 7.19 (s, 1h), 7.10 (m, 2h), 5.18 (s, 2h), 4.52 (s, 1h),3.54(s,1h),3.58(m,1h),2.86(m,1h),2.61(m,1h),2.06(s,3h),1.38(s,9h);esi/ms: M/z=632 (m+h)+.
Embodiment 12: the preparation of compound 6
By compound 10 (9.4g, 14.9mmol), methyl alcohol (60ml, 6v) is added in 100ml hydrogenation bottle, adds 1g 10%pd/c, under 50psi Hydrogen Vapor Pressure, is stirred at room temperature 2 hours, and tlc monitoring cbz protection is sloughed, and is filtered to remove pd/c, filtrate Put into 250ml there-necked flask, temperature control drips the solution of 4m hcl/ ethyl acetate (12ml), reaction overnight at being less than 25 DEG C, tlc supervises Control raw material reaction completely, concentrates, and oil pump draws dry product crude product, recrystallizes to obtain white solid (4.6g, yield 78%, purity 97.9%).
1h nmr(cd3od,500mhz):δppm 8.45(s,1h),8.25(brs,1h),7.98(s,1h),7.61(m, 4h),7.37(s,1h),7.16(s,1h),7.10(m,1h),7.00(m,1h),4.18(m,1h),4.03(m,1h),3.56(m, 1h),3.10(m,1h),3.00(m,1h),2.62(s,3h);Esi/ms:m/z=398 (m+h)+.
The invention provides a kind of synthetic method of atp competitiveness small molecule akt inhibitor a443654, process is simple, always High income, low production cost, environmentally friendly, suitable large-scale production.
The all documents referring in the present invention are all incorporated as reference in this application, independent just as each document It is incorporated as with reference to like that.In addition, it is to be understood that after the above-mentioned instruction content having read the present invention, those skilled in the art can To make various changes or modifications to the present invention, these equivalent form of values equally fall within the model that the application appended claims are limited Enclose.

Claims (10)

1. a kind of synthetic method for preparing atp competitiveness small molecule akt inhibitor a443654 is it is characterised in that the method Comprise the steps of:
1) compound 1 in the basic conditions, is reacted with amido protecting agent, prepared compound 2;
2) in the basic conditions, palladium reagent catalysis is lower and di- pinacol boron ester occurs suzuki coupling reaction, is obtained for compound 2 Compound 3;
3) compound 4 and compound 3, under conditions of alkali, carries out suzuki coupling reaction, prepared compound under palladium reagent catalysis 5;
4) compound 5 sloughs amino protecting group, prepared compound 6;
Wherein, r is tertbutyloxycarbonyl (boc) or benzyloxycarbonyl group (cbz), fluorenylmethyloxycarbonyl (fmoc) or allyloxycarbonyl Or trimethylsilyl ethoxycarbonyl (alloc).
2. synthetic method as claimed in claim 1 is it is characterised in that in step 1, described alkali is sodium carbonate, potassium carbonate, carbonic acid Caesium, sodium acid carbonate, saleratus, NaOH, potassium hydroxide, lithium hydroxide, barium hydroxide, or pyridine, triethylamine, diisopropyl Base ethylamine, pyridinium tosylate, the molar feed ratio of described alkali and compound 1 is 0.05~15:1;Described amido protecting Reagent is selected from di-tert-butyl dicarbonate (boc2O), benzyl chloroformate (cbzcl), chloro-carbonic acid -9- fluorenyl methyl ester (fmoc-cl), chlorine Allyl formate (alloc-cl), n- [2- (trimethyl silicon substrate) ethoxy carbonyloxy group] succinimide (teoc succinimide), It is 1~10:1 with the molar feed ratio of compound 1, and reaction temperature is room temperature to solvent reflux temperature;It is suitable for above-mentioned reaction Solvent is acetonitrile, dichloromethane, ethanol, methyl alcohol, oxolane, dmf, dioxane, ethyl acetate, toluene, chloroform or above-mentioned Any combination of solvent.
3. synthetic method as claimed in claim 2 is it is characterised in that in step 1, described alkali is triethylamine, itself and compound 1 Molar feed ratio be 0.05~5:1;Described amido protecting agent be selected from di-tert-butyl dicarbonate or benzyl chloroformate, itself and The molar feed ratio of compound 1 is 1~3:1;Reaction dissolvent is chloroform, and reaction temperature is solvent reflux temperature.
4. synthetic method as claimed in claim 1 is it is characterised in that in step 2, described alkali is selected from sodium carbonate, potassium carbonate, carbon Sour caesium, sodium acid carbonate, saleratus, NaOH, potassium hydroxide, lithium hydroxide, potassium tert-butoxide, sodium tert-butoxide, potassium acetate, or Pyridine, triethylamine, diisopropyl ethyl amine, it is 1~10:1 with the molar feed ratio of compound 2, and described palladium reagent is selected from pd (dppf)cl2, pd2(dba)3, pd (pph3)4, pd (oh)2, pd (oac)2, its molar feed ratio with compound 2 is 0.05~ 0.3:1, connection boric acid pinacol ester is 1~10:1 with the molar feed ratio of compound 2, and reaction temperature is room temperature to solvent refluxing temperature Degree, the solvent of reaction is dmso, acetonitrile, dichloromethane, ethanol, methyl alcohol, oxolane, dmf, dioxane, ethyl acetate, first Benzene or any combination of above-mentioned solvent, the reaction time is detecting that reaction completes.
5. it is characterised in that in step 2, described alkali is selected from potassium acetate to synthetic method as claimed in claim 1, itself and chemical combination The molar feed ratio of thing 2 is 1~3:1, and described palladium reagent is pd (dppf) cl2, it is 0.01 with the molar feed ratio of compound 2 ~0.5:1, connection boric acid pinacol ester is 1~1.5:1 with the molar feed ratio of compound 2, and reaction temperature is reflux temperature, reaction Solvent be dmso.
6. synthetic method as claimed in claim 1 is it is characterised in that in step 3, described alkali is sodium carbonate, potassium carbonate, carbonic acid Caesium, sodium acid carbonate, saleratus, NaOH, potassium hydroxide, lithium hydroxide, potassium tert-butoxide, sodium tert-butoxide, potassium acetate, or pyrrole Pyridine, triethylamine, diisopropyl ethyl amine, it is 1~10:1 with the molar feed ratio of compound 4, and described palladium reagent is selected from pd (dppf)cl2, pd2(dba)3, pd (pph3)4, pd (oh)2, pd (oac)2, its molar feed ratio with compound 4 is 0.01~ 0.5:1, compound 3 is 1~10:1 with the molar feed ratio of compound 4, and reaction temperature is room temperature to solvent reflux temperature, reaction Solvent be dmso, acetonitrile, dichloromethane, ethanol, methyl alcohol, oxolane, dmf, dioxane, ethyl acetate, toluene, water or Any combination of above-mentioned solvent.
7. synthetic method described as claimed in claim 6 is it is characterised in that in step 3, described alkali is sodium carbonate, its with change Mole feeding intake of compound 4 is ratio 1~4:1, and described palladium reagent is selected from pd (dppf) cl2, it with the molar feed ratio of compound 4 is 0.03~0.3:1, compound 3 is 1~1.2:1 with the molar feed ratio of compound 4, and reaction temperature is reflux temperature, reaction Solvent is the mixture of dioxane and water, and dioxane is 10~1:1 with the volume ratio of water.
8. synthetic method as claimed in claim 7 is it is characterised in that dioxane is 3~1:1 with the volume ratio of water.
9. synthetic method as claimed in claim 1 is it is characterised in that in step 4, when r is for benzyloxycarbonyl group, by palladium carbon hydrogen The method deprotection changed.
10. synthetic method as claimed in claim 9 is it is characterised in that when r is for benzyloxycarbonyl group, using 10%pd/c, hydrogen Pressure is 50psi.
CN201510030110.7A 2015-01-21 2015-01-21 Synthesis method of ATP competitive small-molecule AKT inhibitor A443654 Active CN104610229B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510030110.7A CN104610229B (en) 2015-01-21 2015-01-21 Synthesis method of ATP competitive small-molecule AKT inhibitor A443654

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510030110.7A CN104610229B (en) 2015-01-21 2015-01-21 Synthesis method of ATP competitive small-molecule AKT inhibitor A443654

Publications (2)

Publication Number Publication Date
CN104610229A CN104610229A (en) 2015-05-13
CN104610229B true CN104610229B (en) 2017-01-18

Family

ID=53144914

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510030110.7A Active CN104610229B (en) 2015-01-21 2015-01-21 Synthesis method of ATP competitive small-molecule AKT inhibitor A443654

Country Status (1)

Country Link
CN (1) CN104610229B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CN105189506A (en) * 2012-11-19 2015-12-23 诺华股份有限公司 Compounds and compositions for the treatment of parasitic diseases
BR112015008037A2 (en) * 2012-12-10 2017-07-04 Hoffmann La Roche compounds, process for preparing a compound, pharmaceutical composition, use of the compound, method for treating cancer and invention
WO2014106763A1 (en) * 2013-01-07 2014-07-10 Vichem Chemie Kutató Kft. Pyridopyrazines as anticancer agents

Also Published As

Publication number Publication date
CN104610229A (en) 2015-05-13

Similar Documents

Publication Publication Date Title
CN108047261B (en) Preparation method of clitorium
CN106928214A (en) The preparation method of Yi Zhong oxazolidinone compounds and its intermediate
CN105017082B (en) A kind of preparation method of heart failure medicine Entresto key intermediates (R) tert-butyl group (base of 1 ([1,1` biphenyl] 4 bases) 3 hydroxy propane 2) carbamate
CN107216313B (en) A kind of preparation method of anti-tumor drug AZD9291
CN107207519B (en) Yi Bu replaces the preparation method of Buddhist nun
CN102584795A (en) Preparing method of crizotinib
CN103080088B (en) Production method of intermediate compound for synthesizing medicament
CN106279104B (en) A kind of process modification method preparing amber love song Ge Lieting
CN106749259A (en) A kind of synthetic method of cyclopenta pyrimido azoles
CN103601645B (en) The preparation method of 1-(phenethyl amino) propane-2-alcohol compound or its salt
CN108129513A (en) A kind of method for synthesizing Bouguer and replacing Buddhist nun's intermediate
CN105939995A (en) Synthesis of vortioxetine via (2-(piperazine-1 -yl)phenvl)lithium intermediates
CN107118215B (en) A kind of preparation method for treating breast cancer medicines Rui Boxini intermediate
CN113416150A (en) Novel synthesis method of lobaplatin intermediate
CN110669002B (en) Synthetic method of 2-fluoro-3-hydroxypyridine-4-carboxylic acid
CN104610229B (en) Synthesis method of ATP competitive small-molecule AKT inhibitor A443654
US11161851B2 (en) Processes to produce acalabrutinib
CN108794448B (en) Preparation method of trelagliptin and salt thereof
CN104710417B (en) Azaindole derivatives and synthesis method thereof
CN104109135B (en) 1-[2- (2,4- dimethylphenylsulfanyls)-Ben Ji ]The preparation method of piperazine
CN105924431A (en) Synthesis process for compound crizotinib
CN105503762B (en) A kind of preparation method of 5- aminotetrazoles class compound
CN111362935B (en) Synthesis method of N-hydroxy tropisetron
CN109020977B (en) Preparation method of Acaraburtinib
EP3018115B1 (en) Novel phenyl napthol derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 201203 Shanghai Zhangjiang High Tech Park of Pudong New Area Cailun Road Lane 720 No. 2 Room 601

Patentee after: Shanghai Haoyuan Chemexpress Bio-pharmaceutical Technology Co., Ltd.

Patentee after: Shanghai Hao Yuan pharmaceutical Limited by Share Ltd

Address before: 201203 Shanghai Zhangjiang High Tech Park of Pudong New Area Cailun Road Lane 720 No. 2 Room 601

Patentee before: Shanghai Haoyuan Chemexpress Bio-pharmaceutical Technology Co., Ltd.

Patentee before: Shanghai Haoyuan Chemical Technology Co., Ltd.

CP02 Change in the address of a patent holder

Address after: 3 / F, building 8, No.15 and 16, Lane 1999, zhangheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai, 201203

Patentee after: MEDCHEMEXPRESS CHINA Co.,Ltd.

Patentee after: SHANGHAI HAOYUAN CHEMEXPRESS Co.,Ltd.

Address before: 201203 Room 601, Lane 720, Cailun Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai

Patentee before: MEDCHEMEXPRESS CHINA Co.,Ltd.

Patentee before: SHANGHAI HAOYUAN CHEMEXPRESS Co.,Ltd.

CP02 Change in the address of a patent holder